Literature DB >> 7538206

A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome.

C M Gomez1, J T Gammack.   

Abstract

The slow-channel syndrome is one of several congenital myasthenic syndromes that result from inherited abnormalities of the ion channel of the skeletal muscle acetylcholine receptor (AChR). The ion channel is formed by the second transmembrane domains (M2) of the four AChR subunits. We screened the genomic DNA of one family with the slow-channel syndrome for mutations in the coding sequences for the M2 domains of the four AChR subunits and report the identification of a missense mutation that causes a leucine-to-phenylalanine substitution at position 269 of the epsilon subunit in three affected members of a family with the slow-channel syndrome. We propose that this mutation may be responsible for the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538206     DOI: 10.1212/wnl.45.5.982

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Nicotinic acetylcholine receptors in health and disease.

Authors:  J Lindstrom
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

2.  Analysis of multiple polymorphisms in the bovine neuropeptide Y5 receptor gene and structural modelling of the encoded protein.

Authors:  Tanweer Alam; Bojlul Bahar; Sinéad M Waters; Mark McGee; Torres Sweeney
Journal:  Mol Biol Rep       Date:  2011-09-23       Impact factor: 2.316

3.  Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors.

Authors:  A Kuryatov; V Gerzanich; M Nelson; F Olale; J Lindstrom
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

4.  Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.

Authors:  Christopher M Gomez; Ricardo A Maselli; Bhupinder P S Vohra; Manuel Navedo; Joel R Stiles; Pierre Charnet; Kelly Schott; Legier Rojas; John Keesey; Anthony Verity; Robert W Wollmann; Jose Lasalde-Dominicci
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

5.  Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.

Authors:  C M Gomez; R Maselli; J E Gundeck; M Chao; J W Day; S Tamamizu; J A Lasalde; M McNamee; R L Wollmann
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

6.  Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.

Authors:  Hacer Durmus; Xin-Ming Shen; Piraye Serdaroglu-Oflazer; Bulent Kara; Yesim Parman-Gulsen; Coskun Ozdemir; Joan Brengman; Feza Deymeer; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2017-11-28       Impact factor: 4.296

7.  Zebrafish model for congenital myasthenic syndrome reveals mechanisms causal to developmental recovery.

Authors:  Michael Walogorsky; Rebecca Mongeon; Hua Wen; Nathan R Nelson; Jason M Urban; Fumihito Ono; Gail Mandel; Paul Brehm
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 8.  Decoding pathogenesis of slow-channel congenital myasthenic syndromes using recombinant expression and mice models.

Authors:  José David Otero-Cruz; Carlos Alberto Báez-Pagán; Luisamari Dorna-Pérez; Gary Emanuel Grajales-Reyes; Rosaura Teresa Ramírez-Ordoñez; Carlos A Luciano; Christopher Manuel Gómez; José Antonio Lasalde-Dominicci
Journal:  P R Health Sci J       Date:  2010-03       Impact factor: 0.705

9.  Novel beta subunit mutation causes a slow-channel syndrome by enhancing activation and decreasing the rate of agonist dissociation.

Authors:  Manuel F Navedo; José A Lasalde-Dominicci; Carlos A Báez-Pagán; Luzed Díaz-Pérez; Legier V Rojas; Ricardo A Maselli; Julie Staub; Kelly Schott; Roberto Zayas; Christopher M Gomez
Journal:  Mol Cell Neurosci       Date:  2006-04-19       Impact factor: 4.314

10.  Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia.

Authors:  Li Di; Hai Chen; Yan Lu; Duygu Selcen; Andrew G Engel; Yuwei Da; Xin-Ming Shen
Journal:  Neurology       Date:  2020-09-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.